Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Patten

Showing results (211-220 of 237) with videos related to

Pageof 24
Sort By:
Hemasphere|July 11, 2022
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)Gilles Salles, Stephen J Schuster, Luca Fischer, et al.
Leukemia|June 19, 2021
Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphomaCharlotte Elizabeth Graham, Agnieszka Jozwik, Ruby Quartey-Papafio, et al.
British Journal of Haematology|September 12, 2025
MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapyAndrea Kuhnl, S Bouziana, S F Barrington, et al.
British Journal of Haematology|October 10, 2025
2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemiaR Walewska, T A Eyre, A Bloor, et al.
Blood Advances|October 26, 2021
Early FDG-PET response predicts CAR-T failure in large B-cell lymphomaAndrea Kuhnl, Claire Roddie, Amy A Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2019
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY StudyPeter Hillmen, Andy C Rawstron, Kristian Brock, et al.
British Journal of Haematology|July 3, 2026
Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocolN G Mikhaeel, S Bouziana, M Northend, et al.
Blood|March 10, 2011
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara, Matthew S Kaufman, Carlo Calissano, et al.
Plant Physiology|August 24, 2010
Antisense down-regulation of 4CL expression alters lignification, tree growth, and saccharification potential of field-grown poplarSteven L Voelker, Barbara Lachenbruch, Frederick C Meinzer, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Pageof 24

Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
Hemasphere|July 11, 2022
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)Gilles Salles, Stephen J Schuster, Luca Fischer, et al.
Leukemia|June 19, 2021
Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphomaCharlotte Elizabeth Graham, Agnieszka Jozwik, Ruby Quartey-Papafio, et al.
British Journal of Haematology|September 12, 2025
MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapyAndrea Kuhnl, S Bouziana, S F Barrington, et al.
British Journal of Haematology|October 10, 2025
2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemiaR Walewska, T A Eyre, A Bloor, et al.
Blood Advances|October 26, 2021
Early FDG-PET response predicts CAR-T failure in large B-cell lymphomaAndrea Kuhnl, Claire Roddie, Amy A Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2019
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY StudyPeter Hillmen, Andy C Rawstron, Kristian Brock, et al.
British Journal of Haematology|July 3, 2026
Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocolN G Mikhaeel, S Bouziana, M Northend, et al.
Blood|March 10, 2011
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara, Matthew S Kaufman, Carlo Calissano, et al.
Plant Physiology|August 24, 2010
Antisense down-regulation of 4CL expression alters lignification, tree growth, and saccharification potential of field-grown poplarSteven L Voelker, Barbara Lachenbruch, Frederick C Meinzer, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Pageof 24